# Relmada Therapeutics, Inc.: Form SC 13D/A, filed Jun 2, 2016

- Company: [Relmada Therapeutics, Inc.](/companies/rlmd.md) (CIK 1553643)
- Form: SC 13D/A
- Filed: 2016-06-02
- Accepted by EDGAR: Jun 2, 2016, 08:30 ET
- Period: not reported
- Accession: 0001144204-16-106396
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1553643/000114420416106396/v441467_sc13d-a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1553643/000114420416106396/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1553643/000114420416106396/v441467_sc13d-a.htm

Filed Jun 2, 2016.
Source: SEC EDGAR, the filing index for accession 0001144204-16-106396. Last ingested by Listed: Nov 13, 2026, 15:42 ET. No prices; not investment advice.
